Skip to main content
Metaflammation SFB

News categories: Honors & Funding

Collaborative Research Center "Metaflammation" extended

With the participation of scientists from ImmunoSensation, the Collaborative Research Centre "Metaflammation and Cellular Programming" is investigating the links between lifestyle and inflammatory processes. The German Research Foundation has now extended funding for the research centre.

The CRC 1454 ‘Metaflammation and Cellular Programming’ is already entering its second funding period. It deals with the connection between a Western lifestyle and chronic inflammatory diseases - for example, how an excessive calorie intake coupled with insufficient exercise favours the development of cardiovascular diseases, neurodegenerative diseases or metabolic syndrome.

Using a holistic approach, the researchers are investigating why lifestyle or environmental factors, such as obesity, smoking or insufficient exercise, influence the misprogramming of immune cells and thus cause ‘metaflammation’ - a chronic inflammation triggered by the immune system. The researchers are investigating how the interaction of cells in inflamed tissue takes place and how molecular signalling pathways contribute to the development of diseases during metaflammation.

The scientific network is part of the Transdisciplinary Research Area (TRA) ‘Life and Health’ and combines the expertise of scientists from the Faculty of Medicine, the Faculty of Mathematics and Natural Sciences and the Faculty of Agricultural, Nutritional and Engineering Sciences as well as the Cluster of Excellence ImmunoSensation2 and the University Hospital Bonn (UKB). Researchers from the German Centre for Neurodegenerative Diseases (DZNE) in Bonn, the Max Planck Institute for Metabolic Research in Cologne, the German Rheumatism Research Centre in Berlin and the Technical University of Braunschweig are also involved.

Please visit the CRC Metaflammation website for further information.

 

Contact

Prof. Dagmar Wachten

Institute of Innate Immunity

University Hospital Bonn

E-Mail: dwachten@uni-bonn.de

 

Related news

Speakers of ImmunoSensation

News categories: Honors & Funding

ImmunoSensation goes into the next round

The Bonn Cluster of Excellence ImmunoSensation will be funded for further seven years as part of the Excellence Strategy of the German federal and state governments. The aim of the new funding period, which begins on January 1, 2026, is to research immune diversity: the structural, functional and dynamic diversity of the immune system. Involved are the University of Bonn, the University Hospital Bonn (UKB) and the German Center for Neurodegenerative Diseases (DZNE). The funding amounts to around 50 million euros.
View entry
Kerstin Ludwig

News categories: Honors & Funding

Genome data to improve diagnosis and treatment of long Covid

Despite the many advances, there are still major gaps in the care of patients with long-term and post-COVID. The Institute of Human Genetics at the UKB in Bonn now begins a genomLC study as part of a BMG funding priority. The researchers want to help speed up the diagnosis of long- and post-COVID and identify possible biomarkers that could possibly also differentiate between subgroups of the diseases. To this end, the genomic data of those affected is being analyzed as part of a study using blood samples. The project is funded by the Federal Ministry of Health (BMG) with 1.34 million euros.
View entry
Reckzeh News

News categories: Honors & Funding

Creating Personalized Cancer Treatments

Bonn researchers aim to improve colon cancer treatment using 3D organoids and digital twins. Funded by the Federal Ministry of Education and Research (BMBF), a collaborative project involving the University of Bonn, the company ESQlabs and the University Hospital Bonn is seeking to refine the therapy recommendations given to colon cancer patients. To this end, “ISPOT-K” is merging organoids taken from patients with the power of digital twin technology.
View entry

Back to the news overview